Rifaximin

CAS 80621-81-4

In Stock

Rifaximin

Cat. No. ANT-RFX-000CAS 80621-81-4In Stock

Technical Data

Cat. No.ANT-RFX-000

CAS80621-81-4

Mol. FormulaC₄₃H₅₁N₃O₁₁

Mol. Weight785.88 g/mol

IUPAC[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate

SMILESC[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C

InChIInChI=1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1

InChI KeyNZCRJKRKKOLAOJ-XRCRFVBUSA-N

Purity99%

Description

Overview

Rifaximin, sold under the brand name Xifaxan among others, is an antibiotic medication used to treat travelers' diarrhea, irritable bowel syndrome, and hepatic encephalopathy. It has poor absorption when taken by mouth. It is based on rifamycin. Rifaximin was approved for medical use in the United States in May 2004

Anant Labs manufacture and furnish high quality Rifaximin impurities for global markets. Our Rifaximin EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

4-Deoxy-4'-methylpyridol[1',2'-1,2]imidazo[5,4-c]rifamycin SVRifamycin L 105RifaxidinL-105FatroximinNormixRifacolXifaxanRifaximin80621-81-4

Cat. No.: ANT-RFX-06

In StockRFQ

Rifaximin

Rifaximin

Overview

Synonyms

Impurities (6)

Rifaximin

Rifamycin

Rifaximin EP Impurity A

Rifaximin EP Impurity F

Rifaximin EP Impurity G

Rifaximin Impurity E

Looking for a specific reference standard?